Efficacy and gene expression results from SOLTI1007 NEOERIBULIN phase II clinical trial in HER2-negative early breast cancer Meeting Abstract
| Authors: | Prat, A.; Ortega, V.; Villagrasa, P.; Pare, L.; Galvan, P.; Oliveira, M.; Nuciforo, P.; Lluch, A.; Morales, S.; Amillano, K.; Lopez, R.; Gonzalez, R.; Manso, L.; Martinez, J.; Llombart, A.; De la Pena, L.; Di Cosimo, S.; Rubio, I. T.; Harbeck, N.; Baselga, J.; Cortes, J. |
| Abstract Title: | Efficacy and gene expression results from SOLTI1007 NEOERIBULIN phase II clinical trial in HER2-negative early breast cancer |
| Meeting Title: | 2016 San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 77 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2016 Dec 6-10 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2017-02-01 |
| Language: | English |
| ACCESSION: | WOS:000397999000258 |
| DOI: | 10.1158/1538-7445.sabcs16-p1-09-09 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P1-09-09 -- Source: Wos |
